Thomas Feeny, PA-C

NPI: 1467478024
Total Payments
$3,232
2024 Payments
$2,637
Companies
19
Transactions
139
Medicare Patients
2,426
Medicare Billing
$343,401

Payment Breakdown by Category

Food & Beverage$3,148 (97.4%)
Education$84.00 (2.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,148 138 97.4%
Education $84.00 1 2.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $617.85 31 $0 (2024)
Janssen Biotech, Inc. $604.23 19 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $591.59 35 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $329.04 13 $0 (2024)
Lilly USA, LLC $190.06 9 $0 (2024)
GENZYME CORPORATION $182.79 4 $0 (2024)
Ardelyx, Inc. $165.17 8 $0 (2024)
Medtronic, Inc. $121.62 1 $0 (2024)
QOL Medical, LLC $105.23 5 $0 (2024)
Digestive Care, Inc. $62.35 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,637 116 Janssen Biotech, Inc. ($550.79)
2023 $582.74 22 ABBVIE INC. ($197.90)
2021 $13.14 1 BOSTON SCIENTIFIC CORPORATION ($13.14)

All Payment Transactions

139 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.05 General
Category: Gastroenterology
12/20/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $25.83 General
Category: GASTROENTEROLOGY
12/04/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $22.62 General
Category: GASTROENTEROLOGY
12/03/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.12 General
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.55 General
Category: Gastroenterology
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $10.49 General
Category: Gastroenterology
11/26/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $15.61 General
Category: GI
11/21/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $19.12 General
Category: GASTROENTEROLOGY
11/18/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $15.20 General
Category: LIVER DISEASE
11/13/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $24.23 General
Category: THERAPY FOR CSID
11/07/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.46 General
Category: Immunology
11/06/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $112.92 General
Category: Immunology
11/05/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $19.18 General
Category: INTERNAL MEDICINE
10/31/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $12.81 General
Category: IMMUNOLOGY
10/23/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $24.17 General
Category: Immunology
10/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.65 General
Category: Gastroenterology
10/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.33 General
Category: Gastroenterology
10/22/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $14.59 General
Category: INTERNAL MEDICINE
10/17/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $17.40 General
Category: Immunology
10/14/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $28.34 General
Category: Immunology
10/10/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $141.96 General
Category: Immunology
10/10/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $25.78 General
Category: Immunology
10/10/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $12.88 General
Category: Gastroenterology
10/09/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $26.59 General
Category: GASTROENTEROLOGY
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $8.48 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 416 779 $195,569 $53,211
2022 17 610 1,183 $232,992 $85,036
2021 13 686 1,426 $245,650 $106,455
2020 16 714 1,374 $225,150 $98,700
Total Patients
2,426
Total Services
4,762
Medicare Billing
$343,401
Procedure Codes
58

All Medicare Procedures & Services

58 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99349 Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes Office 2023 125 391 $110,653 $28,082 25.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 69 69 $20,562 $7,210 35.1%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 23 29 $13,543 $3,613 26.7%
G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow Office 2023 22 41 $9,635 $2,759 28.6%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 38 65 $5,980 $2,579 43.1%
99348 Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes Office 2023 30 51 $9,333 $2,264 24.3%
99344 Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes Office 2023 29 29 $11,455 $2,076 18.1%
99497 Advance care planning, first 30 minutes Office 2023 20 21 $3,948 $1,341 34.0%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 15 34 $2,856 $1,023 35.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 15 15 $2,040 $892.20 43.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 11 11 $2,804 $814.44 29.0%
99347 Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes Office 2023 19 23 $2,760 $557.10 20.2%
99336 Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes Office 2022 87 378 $85,268 $29,179 34.2%
99349 Established patient home visit, typically 40 minutes Office 2022 115 275 $59,386 $19,179 32.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 56 56 $10,733 $5,890 54.9%
99497 Advance care planning, first 30 minutes Office 2022 62 74 $8,954 $4,410 49.3%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2022 50 103 $9,294 $3,993 43.0%
99496 Transitional care management services for problem of high complexity Office 2022 20 21 $8,295 $3,722 44.9%
99495 Transitional care management services for problem of moderate complexity Office 2022 22 26 $9,517 $3,391 35.6%
99350 Established patient home visit, typically 1 hour Office 2022 16 25 $6,859 $2,417 35.2%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 16 16 $4,105 $2,135 52.0%
99337 Established patient custodial care facility, group care, or assisted living visit, typically 1 hour Office 2022 17 18 $7,018 $2,073 29.5%
99326 New patient custodial care facility, group care, or assisted living visit, typically 45 minutes Office 2022 23 23 $5,448 $1,924 35.3%
99491 Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month Office 2022 27 37 $4,514 $1,724 38.2%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2022 25 56 $3,968 $1,702 42.9%

About Thomas Feeny, PA-C

Thomas Feeny, PA-C is a Physician Assistant healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467478024.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Feeny, PA-C has received a total of $3,232 in payments from pharmaceutical and medical device companies, with $2,637 received in 2024. These payments were reported across 139 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,148).

As a Medicare-enrolled provider, Feeny has provided services to 2,426 Medicare beneficiaries, totaling 4,762 services with total Medicare billing of $343,401. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Dayton, OH
  • Active Since 07/15/2006
  • Last Updated 08/09/2023
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1467478024

Products in Payments

  • XIFAXAN (Drug) $443.98
  • STELARA (Biological) $391.37
  • RINVOQ (Biological) $321.89
  • ENTYVIO (Biological) $301.42
  • DUPIXENT (Biological) $207.22
  • OMVOH (Drug) $169.70
  • IBSRELA (Drug) $165.17
  • TREMFYA (Drug) $159.42
  • TRULANCE (Drug) $147.61
  • VALLEYLAB FT10 (Device) $121.62
  • MAVYRET (Drug) $77.33
  • LINZESS (Drug) $75.03
  • SUCRAID (Drug) $68.78
  • CREON (Drug) $64.28
  • Pertzye (Drug) $62.35
  • REMICADE (Biological) $53.44
  • SKYRIZI (Biological) $47.36
  • TERLIVAZ (Drug) $42.93
  • Sucraid (Drug) $36.45
  • RESMETIROM (Drug) $36.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Dayton